- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive review on time-tested anticancer drug doxorubicin
Authors
Keywords
Doxorubicin, Chemotherapy, Chemoresistance, Immunogenicity, Molecular mechanism
Journal
LIFE SCIENCES
Volume 278, Issue -, Pages 119527
Publisher
Elsevier BV
Online
2021-04-20
DOI
10.1016/j.lfs.2021.119527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis
- (2020) Zeinab Rafiee et al. ARCHIVES OF MEDICAL RESEARCH
- Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
- (2020) Shaolan Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway
- (2020) Yan Mei et al. JOURNAL OF BIOCHEMISTRY
- Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation
- (2020) Adil Farooq Wali et al. Plants-Basel
- Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance
- (2020) Huamei He et al. JOURNAL OF CONTROLLED RELEASE
- Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro
- (2020) Chengyu Xiang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression
- (2019) Zhuanglei Gao et al. Molecular Genetics & Genomic Medicine
- Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency
- (2019) Christina Schindler et al. PLoS One
- Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A
- (2019) Jin-Gang Hou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression
- (2019) Henrike Tscheschner et al. PLoS One
- Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity
- (2019) Guangna Liu et al. ADVANCED MATERIALS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study
- (2019) Brooke E Wilson et al. LANCET ONCOLOGY
- Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
- (2019) Jeonghun Han et al. Journal of Oncology
- Nicorandil combats doxorubicin–induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway
- (2019) Ali Khames et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology
- (2019) Suma Saad et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Influence of the method of preparation on the characteristics and performance of cholesterol-based polymeric nanoparticles for redox-triggered release of doxorubicin in tumor cells
- (2019) Laura Gonzalez-Fajardo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
- (2019) Shen-Jun Yuan et al. JOURNAL OF NANOBIOTECHNOLOGY
- APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
- (2019) Casey D. Stefanski et al. NEOPLASIA
- MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway
- (2018) Tao Tian et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity
- (2018) Ahmed M. Kabel et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
- (2018) Zunyue Zhang et al. ONCOGENE
- Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
- (2018) Stefania Gorini et al. Oxidative Medicine and Cellular Longevity
- Multidrug Resistance Protein 1 Deficiency Promotes Doxorubicin-Induced Ovarian Toxicity in Female Mice
- (2018) Yingzheng Wang et al. TOXICOLOGICAL SCIENCES
- Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
- (2018) Rui Guo et al. Cell Death & Disease
- Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
- (2018) Sivakumar Vijayaraghavalu et al. Drug Delivery and Translational Research
- Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway
- (2018) Yangwei Fan et al. CANCER BIOLOGY & THERAPY
- DOX Loaded Aggregation-induced Emission Active Polymeric Nanoparticles as a Fluorescence Resonance Energy Transfer Traceable Drug Delivery System for Self-indicating Cancer Therapy
- (2018) Cheng Wang et al. Acta Biomaterialia
- Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats
- (2017) Ali Khames et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
- (2017) Zhenyou Zou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy
- (2017) Yanxia Gong et al. Oncotarget
- Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells
- (2017) Wei Xia et al. Oncotarget
- Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
- (2017) Vinodkumar B. Pillai et al. Oncotarget
- Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity
- (2017) Himangshu Sonowal et al. Scientific Reports
- MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
- (2017) Yin-Ping Fan et al. Molecular Therapy-Nucleic Acids
- Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer
- (2017) Menglin Cheng et al. NEOPLASIA
- Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
- (2017) Shashi Kumar Gupta et al. CIRCULATION RESEARCH
- Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
- (2017) Derek W. Edwardson et al. PLoS One
- TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin
- (2016) Jose Felix Moruno-Manchon et al. Aging-US
- miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
- (2016) Zhongwei Yin et al. Aging-US
- Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line
- (2016) Raimonda Kubiliūtė et al. Medicina-Lithuania
- Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue
- (2016) Luana Amorim Biondo et al. PLoS One
- Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
- (2016) MASANORI KAWANO et al. Oncology Letters
- A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
- (2016) Asish K. Ghosh et al. Oncotarget
- Testosterone Antagonizes Doxorubicin‐Induced Senescence of Cardiomyocytes
- (2016) Paola Altieri et al. Journal of the American Heart Association
- Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model
- (2016) S. Rudnick-Glick et al. JOURNAL OF NANOBIOTECHNOLOGY
- Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line
- (2016) Raimonda Kubiliūtė et al. Medicina-Lithuania
- Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
- (2015) Raafat A El-Awady et al. CANCER BIOLOGY & THERAPY
- Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3
- (2015) Christopher M. Schaupp et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression
- (2014) Qinghua Dong et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1-PD-L1 Axis
- (2014) Z.-C. Ding et al. CANCER RESEARCH
- CD8+T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors
- (2014) Jiemiao Hu et al. Molecular Cancer
- Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
- (2014) Yaqiong Zu et al. MOLECULES
- Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model
- (2014) SEIICHIRO INOUE et al. Experimental and Therapeutic Medicine
- The role of iron in anthracycline cardiotoxicity
- (2014) Elena Gammella et al. Frontiers in Pharmacology
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
- (2013) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response
- (2013) Lára Hannesdóttir et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling
- (2013) Erik Wennerberg et al. INTERNATIONAL JOURNAL OF CANCER
- Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
- (2013) Brent A. Hanks et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
- (2012) Robert A. Forrest et al. BIOCHEMICAL PHARMACOLOGY
- Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome
- (2012) Joan Bladé et al. Clinical Lymphoma Myeloma & Leukemia
- Lack of Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures
- (2012) Heather Greenlee et al. INTEGRATIVE CANCER THERAPIES
- Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function
- (2012) Reid Hayward et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
- (2011) Joyce M. Velez et al. PLoS One
- Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition
- (2010) C Ji et al. ONCOGENE
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver
- (2008) N. Kassner et al. DRUG METABOLISM AND DISPOSITION
- Structural Determinants of Substrate Specificity Differences between Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)
- (2008) C. E. Grant et al. DRUG METABOLISM AND DISPOSITION
- A role for ceramide in driving cancer cell resistance to doxorubicin
- (2008) Yong-Yu Liu et al. FASEB JOURNAL
- Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
- (2008) K. E. Coldwell et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started